FibroBiologics, Inc. Share Price
NASDAQ: FBLGFibroBiologics, Inc. Stock Performance
FibroBiologics, Inc. Share Price Today
As of 31 October 2026, FibroBiologics, Inc.'s share price is $0.94. The stock opened at $0.94, compared to its previous close of $0.94. During today's trading session, FibroBiologics, Inc.'s share price traded between $0.94 and $0.94, with an average price of $0.94. Over the past 52 weeks, the stock has recorded a high of $2.82 and a low of $0.19. In terms of performance, FibroBiologics, Inc.'s share price has declined by 29.84% over the last six months and is up 138.60% on a year-on-year basis.
FibroBiologics, Inc. Share Price Chart
FibroBiologics, Inc. Quarterly Profit & Loss
All figures in USD
FibroBiologics, Inc. Annual Profit & Loss
All figures in USD
About FibroBiologics, Inc.
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
FibroBiologics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.23 | $0.94 | -27.69% |
Sep 2026 | $1.78 | $1.30 | -7.47% |
Aug 2026 | $0.80 | $1.41 | +100.71% |
Jul 2026 | $0.93 | $0.70 | -24.89% |
Jun 2026 | $1.12 | $0.93 | -17.52% |
May 2026 | $1.35 | $1.13 | -15.67% |
Apr 2026 | $1.10 | $1.34 | +2.29% |
Mar 2026 | $0.33 | $1.31 | +306.83% |
Feb 2026 | $0.32 | $0.32 | -3.01% |
Jan 2026 | $0.22 | $0.33 | +49.55% |
Dec 2025 | $0.28 | $0.22 | -18.38% |
Nov 2025 | $0.39 | $0.27 | -30.96% |